Singulair Allergy Approval Will Drive Sales Despite OTC Claritin, Merck Says

Merck's Singulair allergic rhinitis indication will help accelerate growth for the asthma drug in 2003, despite the onset of OTC Claritin, Investor Relations Senior Director Mark Stejbach told investors on a Dec. 5 conference call